SIRT3
SIRT3 (sirtuin 3, also known as SIR2L3) is an NAD-dependent protein deacetylase found in the mitochondrial matrix. It deacetylates lysine residues on mitochondrial proteins to regulate cellular energy metabolism. Browse Assay Genie's current range of SIRT3 research reagents below, or read on for the biology behind the target.
SIRT3 is an NAD-dependent protein deacetylase that activates or deactivates mitochondrial target proteins by removing acetyl groups from key lysine residues. Known targets include ACSS1, IDH, GDH, SOD2, PDHA1, LCAD, SDHA, MRPL12 and the ATP synthase subunit ATP5PO. Through these substrates it contributes to the regulation of cellular energy metabolism and is important for regulating tissue-specific ATP levels.
The enzyme has several further roles. In response to metabolic stress, SIRT3 deacetylates the transcription factor FOXO3 and recruits FOXO3 and mitochondrial RNA polymerase POLRMT to mtDNA to promote mtDNA transcription. It regulates ceramide metabolism by deacetylating ceramide synthases CERS1, CERS2 and CERS6, which increases their activity and promotes mitochondrial ceramide accumulation. It also regulates hepatic lipogenesis: using NAD(+) imported by SLC25A47, it triggers activation of PRKAA1/AMPK-alpha signalling, which down-regulates SREBP transcriptional activity and ATP-consuming lipogenesis. Beyond deacetylation, SIRT3 acts as a protein-lysine deacylase, removing benzoyl and lactoyl groups. It catalyses debenzoylation of PPIF and ACLY and delactylation of CCNE2 and histone H4 at Lys-16 (H4K16la).
The SIRT3 gene encodes a member of the sirtuin family, class I subfamily, a group of class III histone deacetylases homologous to yeast Sir2. Its product is described as found exclusively in mitochondria, where it can eliminate reactive oxygen species, inhibit apoptosis and prevent the formation of cancer cells. SIRT3 has been linked to nuclear gene expression, cancer, cardiovascular disease, neuroprotection, ageing and metabolic control. The gene was previously named for its yeast homologue, silent mating type information regulation 2 homolog 3, and the mouse ortholog is Sirt3.
SIRT3 deacetylates enzymes such as IDH, GDH, PDHA1, SDHA and LCAD, making it central to studies of cellular energy metabolism and ATP levels.
SIRT3 activates ceramide synthases CERS1, CERS2 and CERS6 and regulates hepatic lipogenesis through AMPK signalling and SREBP activity.
SIRT3 can eliminate reactive oxygen species and inhibit apoptosis, and it deacetylates the antioxidant enzyme SOD2.
SIRT3 is linked to cancer, cardiovascular disease, neuroprotection, ageing and metabolic control, making it a frequent focus in disease models.
SIRT3 is an NAD-dependent deacetylase in the mitochondrial matrix. It removes acetyl groups from lysine residues on proteins such as SOD2, IDH and ATP5PO, regulating energy metabolism. It also removes benzoyl and lactoyl groups, and promotes mtDNA transcription via FOXO3 and POLRMT under metabolic stress.
The HGNC name is sirtuin 3, the UniProt name is NAD-dependent protein deacetylase sirtuin-3, mitochondrial, and the alias is SIR2L3. Older names refer to the yeast homologue: sirtuin (silent mating type information regulation 2 homolog) 3. It belongs to the sirtuin family, class I subfamily.
SIRT3 is a homologue of yeast Sir2, and the mouse ortholog is Sirt3. NCBI Gene notes that SIRT3 affects cancer, cardiovascular disease, neuroprotection, ageing and metabolic control. Check the datasheet of any product for its validated reactivity.
Other members of the sirtuin family of NAD-dependent deacylases, relevant to mitochondrial and metabolic research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NTG7; product specifications from Assay Genie datasheets.